Koei Chemical Company, Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Koei Chemical Company, Limited with three other
companies in this sector in Japan:
I'rom Group Co Ltd
sales of 10.58 billion Japanese Yen [US$97.21 million]
of which 70%
was Smo Business),
Wakamoto Pharmaceutical Co., Ltd.
(10.74 billion Japanese Yen [US$98.70 million]
of which 64%
was Medical Pharmaceutical Products), and
Biofermin Pharmaceutical Company Limited
(11.54 billion Japanese Yen [US$106.08 million]
of which 63%
was New BioferminS).
Koei Chemical Company, Limited reported sales of ¥18.31 billion (US$168.26 million)
March of 2019.
a very small
increase of 0.9%
versus 2018, when the company's sales were ¥18.14 billion.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Koei Chemical Company, Limited had sales
of ¥18.58 billion.